BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 15658407)

  • 21. Thrombin-antithrombin III complexes in the diagnosis of consumption coagulopathy.
    Sureda A; García Avello A; García Frade J; Carmen Torrado MC
    Am J Hematol; 1991 Jan; 36(1):74-6. PubMed ID: 2006932
    [No Abstract]   [Full Text] [Related]  

  • 22. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
    Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
    Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of human thrombin-antithrombin III complex by enzyme immunoassay.
    Heimburger N; Pelzer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):269-73. PubMed ID: 2465214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
    Bokarev IN; Butorov VN; Loginov LE
    Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
    [No Abstract]   [Full Text] [Related]  

  • 25. Antithrombin deficiency in special clinical syndromes--Part II: panel discussion #2.
    Sacher R
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):67-71. PubMed ID: 8821213
    [No Abstract]   [Full Text] [Related]  

  • 26. Enzyme-linked immunosorbent assay for thrombin-antithrombin III complexes in horses.
    Topper MJ; Prasse KW; Morris MJ; Duncan A; Crowe NA
    Am J Vet Res; 1996 Apr; 57(4):427-31. PubMed ID: 8712502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.
    Kario K; Matsuo T; Kodama K; Matsuo M
    Thromb Res; 1992 Jun; 66(5):509-15. PubMed ID: 1523607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombin/antithrombin III complex in patients with peripheral occlusive arterial disease.
    Rość D; Kotschy M; Rewakovicz M; Listopadzki D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):405-11. PubMed ID: 1703110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of markers of activated coagulation in antithrombin III deficient subjects.
    Demers C; Ginsberg JS; Henderson P; Ofosu FA; Weitz JI; Blajchman MA
    Thromb Haemost; 1992 May; 67(5):542-4. PubMed ID: 1519214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis of predictive state of disseminated intravascular coagulation].
    Yamamoto K; Saito H
    Nihon Rinsho; 1993 Jan; 51(1):74-8. PubMed ID: 8433531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers.
    Kobayashi T; Terao T
    Gynecol Obstet Invest; 1987; 24(3):170-8. PubMed ID: 3319818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [FDP-D dimer and FDP-E fraction (FDP-E)].
    Amemiya N
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():608-10. PubMed ID: 15658402
    [No Abstract]   [Full Text] [Related]  

  • 34. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
    Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thrombin antithrombin III complex (TAT)].
    Sakuragawa N
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():48-50. PubMed ID: 8753177
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypercoagulability and DIC in high-risk infants.
    Suzuki S; Morishita S
    Semin Thromb Hemost; 1998; 24(5):463-6. PubMed ID: 9834014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thrombin-antithrombin III complexes as a measure of effective heparin treatment?].
    Meyer D; Tsakiris DA; Marbet GA
    Schweiz Med Wochenschr; 1989 Sep; 119(39):1352-4. PubMed ID: 2678451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypercoagulability and chronic atrial fibrillation: the role of markers of thrombin generation.
    Soncini M; Casazza F; Mattioli R; Bonfardeci C; Motta A; Cimminiello C
    Minerva Med; 1997 Dec; 88(12):501-5. PubMed ID: 9540779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?
    Schmidt B; Vegh P; Johnston M; Andrew M; Weitz J
    Thromb Haemost; 1993 May; 69(5):418-21. PubMed ID: 8322263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunochemical determination of thrombin-antithrombin III and plasmin-antiplasmin complexes in human plasma.
    Collen D
    Verh K Acad Geneeskd Belg; 1979; 41(2):81-166. PubMed ID: 160714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.